Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues $ 249 $ 10,184 $ 347 $ 10,617
Cost of revenues 536 615 1,081 940
Gross profit (loss) (287) 9,569 (734) 9,677
Operating expenses:        
Research and development 2,697 2,574 5,103 4,676
General, administrative and marketing 1,422 1,318 2,898 2,843
Total operating income (loss) (4,406) 5,677 (8,735) 2,158
Financial income (expenses), net 196 85 330 (111)
Net income (loss) for the period $ (4,210) $ 5,762 $ (8,405) $ 2,047
Basic net income (loss) per ordinary share (in Dollars per share) $ (0.37) $ 0.51 $ (0.73) $ 0.18
Diluted net income (loss) per ordinary share (in Dollars per share) $ (0.37) $ 0.49 $ (0.73) $ 0.17
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 11,454,512 11,369,031 11,453,845 11,329,516
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 11,454,512 11,777,139 11,453,845 11,738,884